| Basics |
|
Hyperfine, Inc.
|
| IPO Date: |
January 28, 2021 |
| Sector: |
HYPR |
| Industry: |
Medical Devices |
| Market Cap: |
$104.94M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.08 | 4.67%
|
| Avg Daily Range (30 D): |
$0.05 | 4.21%
|
| Avg Daily Range (90 D): |
$0.06 | 4.24%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.39M |
| Avg Daily Volume (30 D): |
.52M |
| Avg Daily Volume (90 D): |
.53M |
| Trade Size |
| Avg Trade Size (Sh.): |
278 |
| Avg Trade Size (Sh.) (30 D): |
257 |
| Avg Trade Size (Sh.) (90 D): |
279 |
| Institutional Trades |
| Total Inst.Trades: |
12 |
| Avg Inst. Trade: |
$1.27M |
| Avg Inst. Trade (30 D): |
$3.06M |
| Avg Inst. Trade (90 D): |
$3.06M |
| Avg Inst. Trade Volume: |
.55M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.74M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
530.89K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.52
|
$-.14
|
|
|
Diluted EPS
|
$-.52
|
$-.14
|
|
|
Revenue
|
$ 10.59M
|
$ 3.44M
|
$
|
|
Gross Profit
|
$ 4.89M
|
$ 1.85M
|
$
|
|
Net Income / Loss
|
$ -40.05M
|
$ -11.02M
|
$ -9.23M
|
|
Operating Income / Loss
|
$ -40.18M
|
$ -8.92M
|
$
|
|
Cost of Revenue
|
$ 5.71M
|
$ 1.59M
|
$
|
|
Net Cash Flow
|
$ -23.95M
|
$
|
$
|
|
PE Ratio
|
|
|
|
| Splits |
|
Aug 13, 2003:
1:10
|
|
|
|